logo

For the Inventor, By the Inventor

Emeryville, CA, United States of America

Cetus Corporation


USPTO Granted Patents = 212



Trademarks = 2

Forward Citations = 23,643

Loading Chart...
Loading Chart...

223 inventors (with patents filed for the assignee):

goldMedal Danute E Nitecki (17 out of 31 patents)

silverMedal David F Mark (17 out of 19 patents)

bronzeMedal David H Gelfand (14 out of 67 patents)

4.  Leo S Lin (13 out of 13 patents)

5.  Corey H Levenson (13 out of 15 patents)

6.  Shing Chang (13 out of 13 patents)

7.  Kirston E Koths (12 out of 44 patents)

8.  John Geigert (12 out of 13 patents)

9.  Lois Aldwin (11 out of 23 patents)

10.  Saul L Neidleman (11 out of 14 patents)

11.  Kary B Mullis (10 out of 23 patents)

12.  James W Larrick (9 out of 56 patents)

13.  Michael A Innis (9 out of 29 patents)

14.  Robert F Halenbeck (9 out of 40 patents)

15.  Walter J Laird (9 out of 16 patents)


Core Competencies:
Immunosuppression
Interleukin-2
Diphtheria Toxin
Biopolymers
Nucleic Acid Amplification
Monoclonal Antibodies
Recombinant Proteins
Cancer Therapeutics
Vaccine Adjuvants
Protein Formulation
DNA Sequencing
Therapeutic Compositions

212 patents:

1. 5792458 - Mutant diphtheria toxin conjugates (1998-08-11),
2. 5702699 - Process for the recovery of lipophilic proteins (1997-12-30),
3. 5643566 - Formulation processes for lipophilic proteins (1997-07-01),
4. 5620849 - Methods and compositions for identifying inhibitors of papilloma virus (1997-04-15),
5. 5372943 - Lipid microemulsions for culture media (1994-12-13),
6. 5269937 - HPLC light scattering detector for biopolymers (1993-12-14),
7. 5268274 - Methods and nucleic acid sequences for the expression of the cellulose (1993-12-07),
8. 5252603 - Immunosuppressive analogues and derivatives of succinylacetone (1993-10-12),
9. 5250186 - HPLC light scattering detector for biopolymers (1993-10-05),
10. 5220004 - Methods and reagents for .sup.G -65 -globin typing (1993-06-15),
11. H001198 - Pseudomonas aeruginosa type-specific human monoclonal antibodies, their (1993-05-31),
12. 5216005 - Immunosuppressive analogues and derivatives of succinylacetone (1993-06-01),
13. 5208021 - Method of preparing diphtheria immunotoxins (1993-05-04),
14. 5173482 - Immunosuppressive analogues and derivatives of succinylacetone (1992-12-22),
15. 5166133 - Method for inhibing adhesion of white blood cells to endothelial cells (1992-11-24),
Company Overview
Cetus Corporation, based in Emeryville, CA, specializes in the development of innovative immunotherapy solutions aimed at treating various cancers. The company focuses on advanced technologies such as immunosuppression and the use of interleukin-2, alongside pioneering applications of diphtheria toxin and biopolymers. Cetus is also engaged in the research and production of monoclonal antibodies, recombinant proteins, and nucleic acid amplification techniques, positioning itself at the forefront of cancer therapeutics.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

212 Patents

#4 in Emeryville, CA

#426 in California

#1,964 in US

#4,013 in the World

Emeryville, CA (US)
Emeryville, CA, United States of America

Cetus Corporation

Forward Citations = 23,643

223 inventors:

goldMedal Danute E Nitecki (17 out of 31 patents)

silverMedal David F Mark (17 out of 19 patents)

bronzeMedal David H Gelfand (14 out of 67 patents)

4.  Leo S Lin (13 out of 13 patents)

5.  Corey H Levenson (13 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cetus Corporation. Retrieved from https://idiyas.com/company/cetus

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…